Clinical trial
Is VEGF a Useful Serum Biomarker for Patients Diagnosed With Meningioma or Glioma?
NCT00985036 is registered in ClinicalTrials.gov with Marquette General Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Is VEGF a Useful Serum Biomarker for Patients Diagnosed With Meningioma or Glioma?
- Lead sponsor
- Marquette General Health System
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- September 30, 2009
- Completion date
- January 31, 2012
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.